Clinical Trials Directory

Trials / Completed

CompletedNCT02385630

Longitudinal Assessment of Gut Hormone Secretion Following Upper Gastrointestinal Surgery for Cancer

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
St. James's Hospital, Ireland · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Surgery is the cornerstone of treatment for patients with oesophageal or gastric cancer, but while surgical removal of the tumour (oesophagectomy or gastrectomy) may offer the best chance of cure, these are major operations associated with specific long term complications. Weight loss and poor nutrition are relatively common problems among patients who attain long-term cancer remission and cure after surgery. The mechanisms underlying these problems are not well understood and therefore treatment options are limited. The investigators research has demonstrated increased levels of chemical messengers (gut hormones) released from the gastrointestinal tract after meals in patients who have previously undergone upper gastrointestinal surgery. These chemical messengers play a role in signalling the feeling of fullness during and after a meal (satiety). Understanding the mechanisms involved in increased gut hormone secretion after these operations may allow us to use certain medications to block gut hormone release and hence reduce satiety allowing patients to eat more, regain weight and prevent nutritional complications after surgery. Exaggerated post-prandial satiety gut hormone responses following oesophagectomy have, however, only been established cross-sectionally and therefore the time course for development of increased gut hormone secretion is unknown. Data collected from this study will provide important information about optimal timing of therapeutic intervention in this patient group, while offering mechanistic insights with regard to the pathophysiologic process underlying post-operative early satiety.

Conditions

Interventions

TypeNameDescription
OTHERStandardized 400kcal semi-liquid mealUsed to assess post-prandial gut hormone response pre-operatively and at 10 days, 4 weeks, 6 months and 12 months post-operatively.

Timeline

Start date
2015-03-01
Primary completion
2018-07-01
Completion
2018-07-01
First posted
2015-03-11
Last updated
2021-08-18

Locations

1 site across 1 country: Ireland

Source: ClinicalTrials.gov record NCT02385630. Inclusion in this directory is not an endorsement.